FDA Inspection 822697 — Pierre Fabre Medicament
The FDA completed an inspection of Pierre Fabre Medicament on Mar 14, 2013 in Gaillac. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 14, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gaillac (France)